Received Jun 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EL9262 | IM / AR |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EN6198 | IM / AR |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 3 | FF2587 | IM / AR |
PFIZER #1 1/27/2021 PFIZER #2 2/22/2021 PFIZER #3 12/29/2021 NO IMMEDIATE REACTION SUFFERED VACCINE FAILURE WITH 7/2022 ACUTE COVID-19 ILLNESS ON A CRUISE SHIP WAS LOCKED DOWN IN CABIN WITH MODERATE SYMPTOMS. SINCE THAT TIME HAS BEEN ANXIOUS AND WORRIED ABOUT LONG TERM RISKS WITH MRNA. WAS FOUND IN 2025 TO HAVE ELEVATED ANTIBODIES TO SPIKE > 10,000 HAS REDUCED ON PROTOCOL BASE SPIKE DETOXIFICATION. EXAM FOUND TRACE PERICARDIAL EFFUSION ON ECHOCARDIOGRAPHY SO DIAGNOSED WITH SUBCLINICAL COVID-19 VACCINE MYOPERICARDITIS WILL TREAT WITH CONTINUED PROTOCOL. SHARED DECISION MAKING NOT TO PRESCRIBE COLCHICINE AT THIS TIME. .
HYPOTHYROIDISM, HTN
LEVOTHYROXINE, AMLODIPINE
PCN
EXAM, ECG, LABS, ECHOCARDIOGRAPHY